RedHill Biopharma (RDHL) Raw Materials (2018 - 2024)
RedHill Biopharma (RDHL) posted quarterly Raw Materials of $513000.0 for Q4 2024, down 38.04% year-over-year from $828000.0 in Q1 2024, and down 38.04% quarter-over-quarter from $828000.0 in Q4 2023.
RedHill Biopharma (RDHL) Raw Materials (2018 - 2024) Analysis & Trends
RedHill Biopharma (RDHL) has reported Raw Materials for 7 consecutive years, with $513000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Raw Materials fell 38.04% year-over-year to $513000.0; the TTM figure through Dec 2024 stood at $513000.0 (down 38.04% YoY), while the FY2024 annual figure was $513000.0, down 38.04% from the prior year.
- Raw Materials eased to $513000.0 in Q4 2024 per RDHL's latest filing, from $828000.0 in the prior quarter.
- Across five years, Raw Materials topped out at $3.0 million in Q4 2021 and bottomed at $513000.0 in Q4 2024.
- Historically, Raw Materials has averaged $1.6 million across 5 years, with a median of $1.8 million in 2020.
- Annual changes were most pronounced in 2021 — Raw Materials jumped 68.08% — and 2023, when it tumbled 53.92%.
- RedHill Biopharma's Raw Materials stood at $1.8 million in 2020, then surged by 68.08% to $3.0 million in 2021, then slumped by 40.34% to $1.8 million in 2022, then slumped by 53.92% to $828000.0 in 2023, then tumbled by 38.04% to $513000.0 in 2024.
- Business Quant data shows RDHL's Raw Materials at $513000.0 in Q4 2024, $828000.0 in Q4 2023, and $1.8 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 513,000.00 |
| Dec 31, 2023 | 828,000.00 |
| Dec 31, 2022 | 1.80 Mn |
| Dec 31, 2021 | 3.01 Mn |
| Dec 31, 2020 | 1.79 Mn |
| Dec 31, 2019 | 1.59 Mn |
| Dec 31, 2018 | 507,000.00 |